Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.16
Delayed Data
As of May 23
 -0.01 / -0.46%
Today’s Change
1.35
Today|||52-Week Range
4.13
+27.06%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.17
Today’s open2.11
Day’s range2.09 - 2.26
Volume72,207
Average volume (3 months)359,844
Market cap$47.0M
Data as of 4:00pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)+26.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+34.26%
P/E ratioNM
Price/Sales1.27
Price/Book17.74

Competitors

 Today’s
change
Today’s
% change
OREXQOrexigen Therapeutic...0.000.00%
PRPHProPhase Labs Inc+0.09+2.24%
FCSCFibrocell Science In...-0.03-4.87%
PULMPulmatrix Inc-0.01-2.38%
Data as of 3:59pm ET, 05/23/2018

Financials

Last reporting dateMay 15, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$26.8M
Annual profit (last year)-$12.0M
Net profit margin-44.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts